A Study of SHR6390 Combined With Famitinib in the Treatment of ER + / HER2- Advanced Breast Cancer
Clinical trial NCT05103826 · TERMINATED
Trial details
- NCT number
- NCT05103826
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-25
- Primary completion
- 2023-06-15
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.